Federal contract award
36C24526N0290
MAVACAMTEN (CAMZYOS) AND POMALIDOMIDE (POLMALYST)
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Veterans Affairs |
| Office | 245-NETWORK CONTRACT OFFICE 5 (36C245) |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | 36E79726A0010 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $365.1K |
| Current contract value | $365.1K |
| Potential contract value / ceiling | $365.1K |
| Start date | Jan 29, 2026 |
| Current end date | Sep 30, 2026 |
| Potential end date | Sep 30, 2026 |
| Latest award activity | Aug 2, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 2, 2026 | P00001 | $8.6K | MAVACAMTEN (CAMZYOS) AND POMALIDOMIDE (POLMALYST) |
| Feb 11, 2026 | 0 | $356.5K | MAVACAMTEN (CAMZYOS) AND POMALIDOMIDE (POLMALYST) |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.